Abstract
Chronic infection with Helicobacter pylori causes peptic ulcers, gastric cancer and lymphoma. We evaluated the inhibitory effects of the probiotic Lactobacillus acidophilus DDS-1J, the antibiotic clarithromycin and the natural antioxidants garcinol and Protykin® (containing 50% trans-resveratrol) on Helicobacter pylori strain ATCC 49503. The findings of this study indicate that Lactobacillus acidophilus DDS-1J exerts a growth inhibitory effect on H. pylori at a ratio of 1:1 or higher in vitro. In the case of clarithromycin, garcinol and resveratrol, the bactericidal effect is time and concentration dependent. Clarithromycin completely inhibited growth at ≥ 62.5 μg/ml at 6 h and at ≥ 31.5 μg/ml at 12 h. For garcinol the highest concentration needed for complete inhibition was 31.5 μg/ml at 6 h and 3.9 μg/ml after 12 h incubation. For resveratrol, significant inhibition was noted at 1000 μg/ml at 12 h only. The bactericidal effect of garcinol was reduced by the addition of resveratrol at all concentrations ≤ 125 μg/ml at 6 and 12 h. We conclude from this study that Lactobacillus acidophilus DDS-1J inhibits H. pylori at 1:1 and higher ratios. Also, between the two antioxidants, garcinol is much more potent than resveratrol as a bactericidal agent against H. pylori, and that resveratrol may antagonize this effect. Finally, our study showed equivalent or better bactericidal activity of garcinol compared to clarithromycin against H. pylori at 6 and 12 h incubation, indicating a potential role for this antioxidant in treatment for H. pylori infection.
Similar content being viewed by others
References
Wang J, Brooks EG, Bamford KB, Denning TL, Pappo J, Ernst PB: Negative selection of T cells by Helicobacter pylori as a model for bacterial strain selection by immune evasion. J Immun 167: 926-934, 2001
Yang Y, Yang Y, Jeng Y, Chang M, Ni Y: Prevalence and rapid identification of clarithromycin resistant Helicobacter pylori isolates in children. Pediatr Infect Dis J 20: 662-666, 2001
Moss SF: The carcinogenic effect of H. pylori on the gastric epithelial cell. J Physiol Pharmacol 50: 847-856, 1999
Jack RW, Tagg JR, Ray B: Bacteriocins of gram-positive bacteria. Microbiol Rev 59: 171-200, 1995
Shahani KM, Chandan RC: Nutritional and healthful aspects of cultured and culture-containing dairy foods. J Dairy Sci 62: 1685-1694, 1979
Bogovic-Matijasic B, Rogelj I, Nes IF, Holo H: Isolation and characterization of two bacteriocins of Lactobacillus acidophilus LF221. Appl Microbiol Biotechnol 49: 606-612, 1998
Bagchi D, Bhattacharya G, Stohs SJ: Production of reactive oxygen species by gastric cells in association with Helicobacter pylori. Free Radic Res 24: 439-450, 1996
Bagchi D, McGinn TR, Ye X, Bagchi M, Krohn RL, Chatterjee A, Stohs SJ: Helicobacter pylori-induced oxidative stress and DNA damage in a primary culture of human gastric mucosal cells. Dig Dis Sci 47: 1405-1412, 2002
Krishnamurthy N, Lewis YS, Ravindranath B: On the structures of garcinol, isogarcinol and camboginol. Tetrahedron Lett 22: 793-796, 1981
Krishnamurthy N, Ravindranath B: Crystal and molecular structure of isogarcinol. Tetrahedron Lett 23: 2233-2236, 1982
Yamaguchi F, Ariga T, Yoshimura Y, Nakazawa H: Anti-oxidative and anti-glycation activity of garcinol from Garcinia indica fruit rind. J Agric Food Chem 48: 180-185, 2000
Mahady GB, Pendland S: Resveratrol inhibits growth of Helicobacter pylori in vitro. Am J Gastroenterol 95: 1849, 2000
Daroch F, Hoeneisen M, Gonzalez CL, Kawaguchi F, Salgado F, Solar H, Garcia A: In vitro antibacterial activity of Chilean red wines against Helicobacter pylori. Microbios 104: 79-85, 2001
Cover TL, Blaser MJ: Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem 267: 10570-10575, 1992
Marshall BJ, Warren JR, Francis GJ, Langton SR, Goodwin CS, Blincow E: Rapid urease test in the management of Campylobacter pyloridis-associated gastritis. Am J Gastroenterol 82: 200-210, 1987
Wilkinson M: Helicobacter pylori: An overview. Br J Biomed Sci 58: 59-60, 2001
Brown LM: Helicobacter pylori: Epidemiology and routes of transmission. Epidemiol Rev 22: 283-297, 2000
Blaser MJ, Berg DE: Helicobacter pylori genetic diversity and risk of human disease. J Clin Invest 107: 767-773, 2001
Fennerty MB: Helicobacter pylori. Arch Intern Med 154: 721-727, 1994
Leung WK, Graham DY: Clarithromycin for Helicobacter pylori infection. Expert Opin Pharmacother 1: 507-514, 2000
Davies GR, Simmonds NJ, Stevens TR, Sheaff MT, Banatvala N, Laurenson IF, Blake DR, Rampton DS: Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut 35: 179-185, 1994
Marshall BJ, Warren JR: Unidentified curved bacilli in the stomach of patients with gastritis. Lancet i: 1311-1315, 1983
Levi S, Beardshall K, Haddad G, Playford R, Ghosh P, Calam J: Campylobacter pylori and duodenal ulcers, the gastrin link. Lancet i: 1167-1168, 1989
Aguilar GR, Ayala G, Fierros-Zarate G: Helicobacter pylori: Recent advances in the study of its pathogenicity and prevention. Salud Publica Mex 43: 237-247, 2001
Kozu T, Saito D: Helicobacter pylori and gastric disease. Rinsho Byori 49: 121-125, 2001
Van der Vliet A, Bast A: Role of reactive oxygen species in intestinal diseases. Free Rad Biol Med 12: 499-513, 1992
McCord JM: Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312: 159-163, 1985
Adkison D, Hollwarth ME, Benoit JN, Parks DA, McCord JM, Granger DN: Role of free radicals in ischemia-reperfusion injury to the liver. Acta Physiol Scand Suppl 548: 101-107, 1986
Schoenberg MH, Buchler M, Gaspar M, Stinner A, Younes M, Melzner I, Bultmann B, Beger HG: Oxygen free radicals in acute pancreatitis of the rat. Gut 31: 1138-1143, 1990
Simmonds NJ, Rampton DS: Inflammatory bowel disease — a radical review. Gut 34: 865-868, 1993
Mansbach CM II, Rosen GM, Rahn CA, Strauss KE: Detection of free radicals as a consequence of rat intestinal cellular drug metabolism. Biochim Biophys Acta 888: 1-9, 1986
Salim AS: The relationship between Helicobacter pylori and oxygen-derived free radicals in the mechanism of duodenal ulceration. Intern Med 32: 359-364, 1993
Ching TL, Haenen GR, Bast A: Cimetidine and other H2-receptor antagonists as powerful hydroxyl radical scavengers. Chem Biol Interact 86: 119-127, 1993
Helicobacter pylori Infections. Red Book 2000. Report of the Committee on Infectious Diseases, American Academy of Pediatrics, 25th ed. 275 pp
Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ: Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr 135: 564-568, 1999
Hsieh PF, Yang JC, Lin JT, Wang JT: Molecular mechanisms of clarithromycin resistance in Helicobacter pylori. J Formos Med Assoc 97: 445-452, 1998
Hulten K, Gibreel A, Skold O, Engstrand L: Macrolide resistance in Helicobacter pylori: Mechanism and stability in strains from clarithromycin-treated patients. Antimicrob Agents Chemother 41: 2550-2553, 1997
Lorca GL, Wadström T, de Valdez GF, Ljungh Å: Lactobacillus acidophilus autolysins inhibit Helicobacter pylori in vitro. Curr Microbiol 42: 39-44, 2001
Cocconnier MH, Liévin V, Hemery S, Servin AL: Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl Environ Microbiol 64: 4573-4580, 1998
Felley CP, Corthesy-Theulaz I, Rivero JL, Sipponen P, Kaufmann M, Bauerfeind P, Wiesel PH, Brassart D, Pfeifer A, Blum AL, Michetti P: Favorable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man. Eur J Gastroenterol Hepatol 13: 25-29, 2001
Canducci F, Armuzzi A, Cremonini F, Cammarota G, Bartolozzi F, Pola P, Gasbarrini G, Gasbarrini A: A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol Ther 14: 1625-1629, 2000
Michetti P, Dorta G, Wiesel PH, Brassart D, Verdu E, Herranz M, Felley C, Porta N, Rouvet M, Blum AL, Corthesy-Theulaz I: Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion 60: 203-209, 1999
Yamaguchi F, Saito M, Ariga T, Yoshimura Y, Nakazawa H: Free radical scavenging activity and antiulcer activity of garcinol from Garcinia indica fruit rind. J Agric Food Chem 48: 2320-2325, 2000
Sato M, Maulik G, Bagchi D, Das DK: Myocardial protection by Protykin®, a novel extract of trans-resveratrol and emodin. Free Radic Res 32: 135-144, 2000
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chatterjee, A., Yasmin, T., Bagchi, D. et al. The bactericidal effects of Lactobacillus acidophilus, garcinol and Protykin® compared to clarithromycin, on Helicobacter pylori . Mol Cell Biochem 243, 29–35 (2003). https://doi.org/10.1023/A:1021649427988
Issue Date:
DOI: https://doi.org/10.1023/A:1021649427988